Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers

Journal of Hospital Infection

Volumn 94, Issue 1, 2016, Pages 54-59

  Dickstein, Y ^a,b   Edelman, R ^b   Dror, T ^b   Hussein, K ^a,b   Bar Lavie, Y ^b,c   Paul, M ^a,b  

^a Infectious Diseases Unit   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c NONE   (Israel)

Author keywords

Carbapenem resistant Enterobacteriaceae; Colonization; Infection; Invasiveness; Virulence

Indexed keywords

ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIUM CARRIER; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CHRONIC KIDNEY DISEASE; CITROBACTER KOSERI; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ENTEROBACTER; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE; KIDNEY FAILURE; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; ADOLESCENT; AGED; ANTIBIOTIC RESISTANCE; CRITICAL ILLNESS; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; RISK FACTOR; YOUNG ADULT;

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CARRIER STATE; CRITICAL ILLNESS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84990857197     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2016.05.018     Document Type: Article

References (33)

1. 1 Schwaber, M.J., Klarfield-Lidji, S., Navon-Venezia, S., Schwartz, D., Leavitt, A., Carmeli, Y., Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52 (2008), 1028–1033.
2. 2 Gasink, L.B., Edelstein, P.H., Lautenbach, E., Synnestvedt, M., Fishman, N.O., Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 30 (2009), 1180–1185.
3. 3 Falagas, M.E., Tansarli, G.S., Karageorgopoulos, D.E., Vardakas, K.Z., Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 20 (2014), 1170–1175.
4. 4 Swaminathan, M., Sharma, S., Poliansky Blash, S., et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 34 (2013), 809–817.
5. 5 Bhargava, A., Hayakawa, K., Silverman, E., et al. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol 35 (2014), 398–405.
6. 6 Siu, L.K., Lin, J.C., Gomez, E., Eng, R., Chiang, T., Virulence and plasmid transferability of KPC Klebsiella pneumoniae at the Veterans Affairs Healthcare System of New Jersey. Microb Drug Resist 18 (2012), 380–384.
7. 7 Lavigne, J.P., Cuzon, G., Combescure, C., Bourg, G., Sotto, A., Nordmann, P., Virulence of Klebsiella pneumoniae isolates harboring bla KPC-2 carbapenemase gene in a Caenorhabditis elegans model. PloS One, 8, 2013, e67847.
8. 8 Beceiro, A., Tomás, M., Bou, G., Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?. Clin Microbiol Rev 26 (2013), 185–230.
9. 9 Daikos, G.L., Vryonis, E., Psichogiou, M., et al. Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase. J Antimicrob Chemother 65 (2010), 784–788.
10. 10 Borer, A., Saidel-Ores, L., Eskira, S., et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K. pneumoniae. Am J Infect Control 40 (2012), 421–425.
11. 11 Schechner, V., Kotlovsky, T., Kazma, M., et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?. Clin Microbiol Infect 19 (2013), 451–456.
12. 12 Pratikaki, M., Platsouka, E., Sotiropoulou, C., et al. Risk factors for and influence of bloodstream infections on mortality: a 1-year prospective study in a Greek intensive-care unit. Epidemiol Infect 137 (2009), 727–735.
13. 13 Deitch, E.A., Gut-origin sepsis: evolution of a concept. Surgeon 10 (2012), 350–356.
14. 14 Papadimitriou-Olivgeris, M., Marangos, M., Fligou, F., et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 67 (2012), 2976–2981.
15. 15 Papadimitriou-Olivgeris, M., Marangos, M., Fligou, F., et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 77 (2013), 169–173.
16. 16 Vasudevan, A., Mukhopadhyay, A., Goh, E.Y., Li, J., Tambyah, P.A., Risk factors for infection/colonization caused by resistant Gram negative bacilli in critically ill patients (an observational study of 1633 critically ill patients). Prev Med 57:Suppl. (2013), S70–S73.
17. 17 Hussein, K., Raz-Pasteur, A., Finkelstein, R., et al. Impact of carbapenem resistance on the outcome of patients’ hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect 83 (2013), 307–313.
18. 18 Dautzenberg, M.J., Wekesa, A.N., Gniadkowski, M., et al. The association between colonization with carbapenemase-producing Enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med 43 (2015), 1170–1177.
19. 19 Putter, H., Fiocco, M., Geskus, R.B., Tutorial in biostatistics: competing risks and multi-state models. Stat Med 26 (2007), 2389–2430.
20. 20 Andersen, P.K., Geskus, R.B., de Witte, T., Putter, H., Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41 (2012), 861–870.
21. 21 Knaus, W.A., Draper, E.A., Wagner, D.P., Zimmerman, J.E., APACHE II: a severity of disease classification system. Crit Care Med 13 (1985), 818–829.
22. 22 Akaike, H., A new look at the statistical model identification. IEEE Trans Auto Control 19 (1974), 716–723.
23. 23 Andrade, L.N., Vitali, L., Gaspar, G.G., Bellissimo-Rodrigues, F., Martinez, R., Darini, A.L., Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J Clin Microbiol 52 (2014), 2530–2535.
24. 24 Ramos, P.I., Picão, R.C., Almeida, L.G., et al. Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire or virulence and resistance mechanisms. BMC Genom, 15, 2014, 54.
25. 25 Fuursted, K., Schøler, L., Hansen, F., et al. Virulence of a Klebsiella pneumoniae strain carrying the New Delhi metallo-beta-lactamase-1 (NDM-1). Microbes Infect 14 (2012), 155–158.
26. 26 McLaughlin, M.M., Advincula, M.R., Malczynski, M., Barajas, G., Qi, C., Scheetz, M.H., Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomes. BMC Infect Dis, 14, 2014, 31.
27. 27 Peirano, G., Mulvey, G.L., Armstrong, G.D., Pitout, J.D., Virulence potential and adherence properties of Escherichia coli that produce CTX-M and NDM β-lactamases. J Med Microbiol 62 (2013), 525–530.
28. 28 Brisse, S., Fevre, C., Passet, V., et al. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PloS One, 4, 2009, e4982.
29. 29 Langermann, S., Palaszynski, S., Barnhart, M., et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276 (1997), 607–611.
30. 30 Bachman, M.A., Oyler, J.E., Burns, S.H., et al. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun 79 (2011), 3309–3316.
31. 31 Hussein, K., Sprecher, H., Mashiach, T., Oren, I., Kassis, I., Finkelstein, R., Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 30 (2009), 666–671.
32. 32 Oostdijk, E.A., de Smet, A.M., Kesecioglu, J., Bonten, M.J., Dutch SOD-SDD Trialists Group. The role of intestinal colonization with Gram-negative bacteria as a source for intensive care unit-acquired bacteremia. Crit Care Med 39 (2011), 961–966.
33. 33 Zaborin, A., Smith, D., Garfield, K., et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. Mbio 5 (2014), e01361–e01414.